Sera Prognostics

OverviewSuggest Edit

Sera Prognostics was founded to develop diagnostic tests for the early prediction of a woman’s individualized risk of premature birth, preeclampsia, and other pregnancy complications. Sera’s tests are designed to give women and their physicians the power and time to make a difference in maternal and newborn health with individualized treatment and care plans. The company has completed enrollment and is in the validation phase for the landmark Proteomic Assessment of Preterm Risk (PAPR) clinical study. PAPR is an all-comer study representative of pregnant women in the U.S. It is the largest study of its kind and includes 5,501 women. The company’s proteomic predictor of premature birth risk—the PreTRM® Test for Risk Management-became commercially available in the U.S. in early 2016. VISION: EARLY PREDICTION OF PREMATURE BIRTH, PREECLAMPSIA, AND OTHER PREGNANCY COMPLICATIONS To be a global leader in high-value women’s health diagnostics, delivering pivotal information to patients and physicians that will improve the health of pregnant women and newborns and simultaneously improve the economics of healthcare.
TypePrivate
Founded2008
HQSalt Lake City, US
Websiteseraprognostics.com

Latest Updates

Employees (est.) (Dec 2019)53(-1%)

Key People/Management at Sera Prognostics

Gregory C. Critchfield

Gregory C. Critchfield

Chairman & CEO
Andrew A. Sauter

Andrew A. Sauter

CFO
Show more

Sera Prognostics Office Locations

Sera Prognostics has an office in Salt Lake City
Salt Lake City, US (HQ)
2749 E Parleys Way #200
Show all (1)

Sera Prognostics Financials and Metrics

Summary Metrics

Founding Date

2008

Sera Prognostics total Funding

$150.3 m

Sera Prognostics latest funding size

$36 m

Time since last funding

a month ago

Sera Prognostics investors

Sera Prognostics's latest funding round in November 2019 was reported to be $36 m. In total, Sera Prognostics has raised $150.3 m
Show all financial metrics

Sera Prognostics Online and Social Media Presence

Embed Graph

Sera Prognostics Blogs

NEW SCIENTIFIC PUBLICATION SHOWS SERA PROGNOSTICS IS LEADER IN ASSESSING PRETERM BIRTH RISK

Nov 18, 2019 – Sera announced that a key scientific publication, “Effects of Selective Exclusion of Patients on Preterm Birth Test Performance,” authenticates Sera as the leading authority in using biomarkers to assess preterm birth risk. The post NEW SCIENTIFIC PUBLICATION SHOWS SERA PROGNOSTICS IS…

SERA PROGNOSTICS RAISES $36 MILLION SERIES D FINANCING LED BY BLUE OX HEALTHCARE PARTNERS

Nov. 13, 2019 – Sera announced it has raised $36 million in Series D financing led by Blue Ox Healthcare Partners, an investment firm providing growth capital to healthcare companies targeting individuality and value-based care. The post SERA PROGNOSTICS RAISES $36 MILLION SERIES D FINANCING LED BY…

Sera Prognostics to Present at the 31st Annual Piper Jaffray Healthcare Conference

Nov. 1, 2019 -- Sera Prognostics will be presenting at the upcoming Piper Jaffray Healthcare Conference at the Lotte New York Palace in New York City on Thursday, December 5th at 12:30 p.m. ET. The post Sera Prognostics to Present at the 31st Annual Piper Jaffray Healthcare Conference appeared first…

Sera Prognostics to Present at the 13th Annual Canaccord Genuity Medical Technologies & Diagnostics Forum

Oct. 21, 2019 -- Sera Prognostics announced that Gregory C. Critchfield, M.D., M.S., Chairman and CEO, will be presenting at the upcoming Canaccord Genuity Medical Technologies and Diagnostics Forum at the Westin Grand Central Hotel in New York City on Thursday, November 21st, at 3:00 p.m. ET The po…

Supervisor – Accessioning and Sample Management

SUpervisor – Accessioning and sample Management Sera Prognostics, Inc., a women’s health care company, is seeking a driven individual for the role of Supervisor of Sample Accessioning and Management.  This is a full-time, in-house position that will oversee a team of sample processors, and problem r…

Laboratory Automation Engineer

LABoratory Automation engineer Sera Prognostics, Inc., a women’s health care company, is seeking a driven individual for the role of Laboratory Automation Engineer.  The Automation Engineer will contribute to the installation, qualification, validation, troubleshooting and maintenance of simple and …
Show more

Sera Prognostics Frequently Asked Questions

  • When was Sera Prognostics founded?

    Sera Prognostics was founded in 2008.

  • Who are Sera Prognostics key executives?

    Sera Prognostics's key executives are Gregory C. Critchfield and Andrew A. Sauter.

  • How many employees does Sera Prognostics have?

    Sera Prognostics has 53 employees.

  • Who are Sera Prognostics competitors?

    Competitors of Sera Prognostics include Kindbody, Geratherm and Future Family.

  • Where is Sera Prognostics headquarters?

    Sera Prognostics headquarters is located at 2749 E Parleys Way #200, Salt Lake City.

  • Where are Sera Prognostics offices?

    Sera Prognostics has an office in Salt Lake City.

  • How many offices does Sera Prognostics have?

    Sera Prognostics has 1 office.